Home - Products - Apoptosis - TNF - Zigakibart

Zigakibart

CAS No. 2642175-46-8

Zigakibart( —— )

Catalog No. M37285 CAS No. 2642175-46-8

Zigakibart (BION-1301) is a humanized monoclonal antibody targeting TNFSF13 with anti-inflammatory activity for the study of immunoglobulin A nephropathy (IgAN).

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	439	Get Quote
5MG	748	Get Quote
10MG	1169	Get Quote
25MG	1684	Get Quote
50MG	2282	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Zigakibart
Note

Research use only, not for human use.
Brief Description

Zigakibart (BION-1301) is a humanized monoclonal antibody targeting TNFSF13 with anti-inflammatory activity for the study of immunoglobulin A nephropathy (IgAN).
Description

Zigakibart (BION-1301) is an IgG4-kappa, anti-TNFSF13 (tumor necrosis factor (TNF) superfamily member 13, APRIL, CD256) humanized monoclonal antibody. Zigakibart shows anti-inflammatory activity.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Apoptosis
Target

TNF
Recptor

TNF
Research Area

——
Indication

——

Chemical Information

CAS Number

2642175-46-8
Formula Weight
Molecular Formula

——
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

HOMOPLANTAGININ

Homoplantaginin is a flavonoid from a traditional Chinese medicine Salvia plebeiait has a protective and therapeutic effect on hepatocyte injury and shows potent inhibitory activities against influenza.
Brentuximab

Brentuximab, a chimeric antibody targeting CD30, is a naked antibody to Brentuximab vedotin. It possesses antitumor activity and may be used to study relapsed or refractory Hodgkin's lymphoma.
Trilobatin

Trilobatin has anti-oxidant effect can increase superoxide dismutase (SOD) activity.Trilobatin has anti-inflammatory effect it potentially inhibits the lipopolysaccharide (LPS)-induced inflammatory response by suppressing the NF-κB signaling pathway.

Sign In Join Free